Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaughan, T. B.
Right arrow Articles by Bell, D. S.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaughan, T. B.
Right arrow Articles by Bell, D. S.H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:2082, 2005
© 2005 by the American Diabetes Association, Inc.

Letters: Observations

Statin Neuropathy Masquerading as Diabetic Autoimmune Polyneuropathy

Tom Brooks Vaughan, MD and David S.H. Bell, MD

Address correspondence and reprint requests to Tom Brooks Vaughan, MD, Division of Endocrinology, University of Alabama School of Medicine, Faculty Office Tower, Suite 758, 510 20th St. S., Birmingham, AL 35294. E-mail: brooks@uab.edu

The first 20% of the full text of this article appears below.

Statin-induced neuropathy is increasingly described. Proposed mechanisms include an alteration in cholesterol synthesis, producing a disturbance in the cholesterol-rich neuronal membrane, or in the activity of ubiquinone (coenzyme Q10), a mitochondrial respiratory chain enzyme inhibited by statins leading to neuronal damage (1). The entire class is implicated, and both polyneuropathy and mononeuropathy have been described with improvement or even complete resolution occurring with cessation of therapy (1). In all cases, clinical improvement occurred soon after statins were discontinued, and in the absence . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
M. Al-Shabrawey, M. Bartoli, A. B. El-Remessy, G. Ma, S. Matragoon, T. Lemtalsi, R. W. Caldwell, and R. B. Caldwell
Role of NADPH Oxidase and Stat3 in Statin-Mediated Protection against Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3231 - 3238.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. Mascitelli and F. Pezzetta
EPIDEMIOLOGY OF DISTAL SYMMETRICAL NEUROPATHIES IN THE ITALIAN ELDERLY
Neurology, October 23, 2007; 69(17): 1728 - 1728.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.